Theranib Inc.
PrivateLast Round
Grant
Apr 1, 2026
Total Funding Raised
$2.78M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Theranib Inc. operates in Healthcare & Life Sciences and is based in Halifax. Its latest recorded funding round was a Grant round in April 2026.
Theranib Inc. is a biotechnology company that develops precision cancer therapies targeting the ALDH1A3 enzyme to combat metastasis and therapy resistance in solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theranib Inc. Comparables
Compare Theranib Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Advanced BioDesign | 80% | |
| Pacylex Pharmaceuticals | 70% | |
| Kayothera | 68% |
For institutional investors. Book with your work email.
Theranib Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2026 | ||||
| Accelerator | Sep 17, 2025 |
For institutional investors. Book with your work email.
Theranib Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Grant |
| Innovacorp | Accelerator, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 494% MoM.
- May 11, 2026
Monthly visitors grew 474% MoM, reaching 1.9K.
For institutional investors. Book with your work email.
Theranib Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Theranib Inc.'s valuation, stock price, and market status.
Is Theranib Inc. a public or private company?
Theranib Inc. is a private company.
What is the current stock price of Theranib Inc.?
Theranib Inc. is a private company, so its shares have no public market price. Caplight tracks Theranib Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Theranib Inc. worth (valuation)?
Valuation information for Theranib Inc. is not publicly available.
Can I buy Theranib Inc. stock?
Theranib Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Theranib Inc.'s last funding round?
Theranib Inc.'s most recent funding round was Grant on April 1, 2026.
Who are the main investors in Theranib Inc.?
Key investors in Theranib Inc. include Canadian Institutes of Health Research, Innovacorp.
Will Theranib Inc. IPO soon?
No public IPO plans have been announced for Theranib Inc..
How can I track Theranib Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Theranib Inc.'s shares on secondary markets.